Raykov Rosty
Director | Chief Executive Officer | Chief Executive Officer
1 company
Insider Signal Score
54
AverageTrades Analyzed
32
12M Win Rate
24.0%
Avg 3M Return
+0.2%
Avg 12M Return
-13.5%
Raykov Rosty is a Director at FENNEC PHARMACEUTICALS INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $1.4M based on current market prices.
Holdings by Company
FENCJun 1, 2026
Current Shares130.1K
Value$1.43M
Net Activity-333,614
Bought: 29.2KSold: 362.8K
Transaction History
Showing 10 filings (page 2)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 10,000 | $6.31 | $63,100.00 | -15.7% | +32.5% | +7.0% | |
| Apr 4, 2025 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 10,000 | $5.25 | $52,500.00 | -14.1% | +67.6% | +22.3% | |
| Mar 5, 2025 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 10,000 | $6.79 | $67,900.00 | -12.7% | +16.7% | +17.5% | |
| Feb 5, 2025 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 10,000 | $6.66 | $66,600.00 | -11.6% | -11.5% | +12.8% | |
| Jan 6, 2025 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 10,000 | $6.08 | $60,800.00 | -5.4% | -14.3% | +21.4% | |
| Dec 5, 2024 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 796 | $6.04 | $4,807.84 | -1.2% | +18.0% | +32.0% | |
| Dec 3, 2024 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 1,635 | $6.13 | $10,022.55 | -2.4% | +8.7% | +21.5% | |
| Nov 4, 2024 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 2,431 | $4.31 | $10,477.61 | -3.5% | +39.8% | +72.0% | |
| Oct 1, 2024 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 2,431 | $4.94 | $12,009.14 | -3.5% | +27.8% | +99.0% | |
| Sep 4, 2024 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 2,431 | $5.52 | $13,419.12 | -3.5% | +12.1% | +65.1% |